相似文献
1
Regulatory changes in presynaptic cholinergic function assessed in rapid autopsy material from patients with Alzheimer disease: implications for etiology and therapy.
Proc Natl Acad Sci U S A. 1990 Apr;87(7):2452-5. doi: 10.1073/pnas.87.7.2452.
2
Overexpression of the high affinity choline transporter in cortical regions affected by Alzheimer's disease. Evidence from rapid autopsy studies.
J Clin Invest. 1994 Aug;94(2):696-702. doi: 10.1172/JCI117387.
3
High affinity choline transporter status in Alzheimer's disease tissue from rapid autopsy.
Ann N Y Acad Sci. 1996 Jan 17;777:197-204. doi: 10.1111/j.1749-6632.1996.tb34419.x.
4
Pre- and post-synaptic cholinergic dysfunction in aged rodent brain regions: new findings and an interpretative review.
Int J Dev Neurosci. 1990;8(6):689-708. doi: 10.1016/0736-5748(90)90063-8.
5
Presynaptic cholinergic dysfunction in patients with dementia.
J Neurochem. 1983 Feb;40(2):503-9. doi: 10.1111/j.1471-4159.1983.tb11311.x.
6
Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease.
J Neural Transm (Vienna). 1998;105(6-7):709-17. doi: 10.1007/s007020050090.
7
Basal synthesis of acetylcholine in hippocampal synaptosomes is not dependent upon membrane-bound choline acetyltransferase activity.
Neuroscience. 1993 Jun;54(3):649-56. doi: 10.1016/0306-4522(93)90236-9.
8
Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease.
Brain Res. 1983 Dec 19;289(1-2):169-75. doi: 10.1016/0006-8993(83)90017-3.
9
The use of choline acetyltransferase as a cholinergic marker in the determination of high-affinity choline uptake.
J Neurochem. 1980 Jun;34(6):1553-6. doi: 10.1111/j.1471-4159.1980.tb11242.x.
10
Choline uptake, acetylcholine synthesis and release, and halothane effects in synaptosomes.
Anesth Analg. 1985 Apr;64(4):395-9.
引用本文的文献
1
Cross-species comparative analysis of single presynapses.
Sci Rep. 2023 Aug 24;13(1):13849. doi: 10.1038/s41598-023-40683-8.
2
The Monkey Head Mushroom and Memory Enhancement in Alzheimer's Disease.
Cells. 2022 Jul 24;11(15):2284. doi: 10.3390/cells11152284.
3
Combination of Polygoni Multiflori Radix Praeparata and Acori Tatarinowii Rhizoma Alleviates Learning and Memory Impairment in Scopolamine-Treated Mice by Regulating Synaptic-Related Proteins.
Front Pharmacol. 2021 Jul 29;12:679573. doi: 10.3389/fphar.2021.679573. eCollection 2021.
4
Chemical Stimulation of Rodent and Human Cortical Synaptosomes: Implications in Neurodegeneration.
Cells. 2021 May 12;10(5):1174. doi: 10.3390/cells10051174.
5
Metabolic Dysregulation Contributes to the Progression of Alzheimer's Disease.
Front Neurosci. 2020 Nov 5;14:530219. doi: 10.3389/fnins.2020.530219. eCollection 2020.
6
Alzheimer's Disease Therapeutic Approaches.
Adv Exp Med Biol. 2020;1195:105-116. doi: 10.1007/978-3-030-32633-3_15.
7
The Promises and Challenges of Erythropoietin for Treatment of Alzheimer's Disease.
Neuromolecular Med. 2019 Mar;21(1):12-24. doi: 10.1007/s12017-019-08524-y. Epub 2019 Jan 17.
8
Pathological Increases in Neuronal Hyperactivity in Selective Cholinergic and Noradrenergic Pathways May Limit the Efficacy of Amyloid-β-Based Interventions in Mild Cognitive Impairment and Alzheimer's Disease.
J Alzheimers Dis Rep. 2018 Oct 3;2(1):165-167. doi: 10.3233/ADR-180077.
9
Therapeutics of Neurotransmitters in Alzheimer's Disease.
J Alzheimers Dis. 2017;57(4):1049-1069. doi: 10.3233/JAD-161118.
10
Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.
J Alzheimers Dis. 2017;57(4):975-999. doi: 10.3233/JAD-160612.
本文引用的文献
1
A post-mortem study of the cholinergic and GABA systems in senile dementia.
Brain. 1982 Jun;105(Pt 2):313-30. doi: 10.1093/brain/105.2.313.
2
Presynaptic cholinergic dysfunction in patients with dementia.
J Neurochem. 1983 Feb;40(2):503-9. doi: 10.1111/j.1471-4159.1983.tb11311.x.
3
Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease.
Brain Res. 1983 Dec 19;289(1-2):169-75. doi: 10.1016/0006-8993(83)90017-3.
4
Biochemical assessment of serotonergic and cholinergic dysfunction and cerebral atrophy in Alzheimer's disease.
J Neurochem. 1983 Jul;41(1):266-72. doi: 10.1111/j.1471-4159.1983.tb11838.x.
5
6
Muscarinic receptor subtypes in hippocampus in Alzheimer's disease and mixed dementia type.
Neurosci Lett. 1986 Sep 25;70(1):160-4. doi: 10.1016/0304-3940(86)90456-8.
7
Nicotinic acetylcholine binding sites in Alzheimer's disease.
Brain Res. 1986 Apr 16;371(1):146-51. doi: 10.1016/0006-8993(86)90819-x.
8
Regulation of adrenal chromaffin cell development by the central monoaminergic system: differential control of norepinephrine and epinephrine levels and secretory responses.
Neuroscience. 1987 Sep;22(3):1067-75. doi: 10.1016/0306-4522(87)92981-2.
9
Cellular localization of messenger RNA encoding amyloid-beta-protein in normal tissue and in Alzheimer disease.
Alzheimer Dis Assoc Disord. 1988;2(2):96-111. doi: 10.1097/00002093-198802020-00002.
10
Diagnosis of Alzheimer's disease.
Arch Neurol. 1985 Nov;42(11):1097-105. doi: 10.1001/archneur.1985.04060100083029.
Zotero 插件